March 30, 2012
PLEASANTON, Calif.,- Roche announced today the FDA approval of a new pre-analytical instrument that provides an integrated primary tube handling solution for its widely adopted automated molecular testing platform. The cobas p 630 Instrument, being introduced with new AMPLILINK 3.3 series software, unites primary tube handling with fully automated sample preparation, amplification and detection for [...]
FDA Detectives use Stomacher® 400 circulator for sample preparation in cantaloupe Listeriosis scare
March 29, 2012
Worthing, UK – Seward, the manufacturer and developer of the patented Stomacher® Paddle Blender range, highlights the use of the Stomacher® 400 Circulator in the elimination of soil and fruit as possible sources in a recent fatal cantaloupe melon Listeriosis scare. At the height of the scare the outbreak detectives of the FDA were mystified [...]
Almac and Affymetrix Announce a Global Distribution Agreement for Almac’s Xcel™ Array
March 29, 2012
Almac today announced that it has signed an exclusive global distribution deal with Affymetrix, Inc. enabling them to directly sell Almac’s proprietary Xcel™ array for biomarker discovery, development and delivery worldwide. Almac’s Xcel™ array is a high density transcriptome-based microarray that has been optimised for the discovery and development of biomarkers from formalin fixed paraffin [...]
GenMark Enters into License Agreement with PerkinElmer for Microfluidics Patent Portfolio
March 29, 2012
CARLSBAD, Calif.-- GenMark Diagnostics, Inc., announced today that it has entered into a license agreement with PerkinElmer, granting GenMark a non-exclusive license under PerkinElmer's microfluidics patent portfolio. "Completing this agreement strengthens GenMark's patent portfolio and provides us with maximum flexibility as we expand our menu of high-value multiplex molecular tests and develop new innovative platforms [...]
Charm Sciences Announces ROSA® FAST5 Family of 5 Minute Quantitative Mycotoxin Test Kits
March 29, 2012
Charm Sciences, Inc. is pleased to announce that the Charm® ROSA FAST5 family of quantitative mycotoxin tests will be launched at the Pet Food Forum held April 2-4, 2012 in Schaumburg, Illinois. These 5 minute mycotoxin tests deliver quantitative detection that is rapid and accurate in feed and grain for aflatoxin, DON and fumonisin. Mycotoxins [...]
March 29, 2012
SANTA CLARA, Calif.--Affymetrix, Inc. (NASDAQ:AFFX) today announced that it has signed a global distribution agreement with Almac Group Ltd., an established company that provides an extensive range of pharmaceutical services. In this agreement, Affymetrix has exclusive rights to distribute Almac’s Xcel™ array for research use in biomarker discovery for multiple disease areas, including cancer. The [...]
Beckman Coulter Life Sciences Acquires Blue Ocean Biomedical
March 29, 2012
Beckman Coulter Life Sciences has acquired Blue Ocean Biomedical, LLC, a Pembroke Pines, Florida-based manufacturer of automated flow cytometry systems and reagents. The transaction provides Beckman Coulter Life Sciences with low complexity analyzers that integrate automated sample preparation and directly address emerging flow cytometry market trends. Driving growth through internal product development and through acquisition [...]
March 29, 2012
TAP Biosystems, a leading supplier of innovative cell culture systems and consumables for life science applications, is pleased to announce it is installing a system to automate the ex-vivo expansion of autologous cell therapies (CellBase CT™) at Czech-based firm PrimeCell, one of Central and Eastern Europe’s largest regenerative medicine companies. The CellBase CT system at [...]
Illumina Advises Stockholders to Defer Taking Any Action in Response to Roche’s Increased Offer
March 29, 2012
SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN), a leading developer, manufacturer and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today recommended that its stockholders take no action at this time in response to Roche’s announcement that it is now offering to acquire Illumina for $51.00 per share [...]
Courtagen Introduces Genomic Profiling Services in their Newly Licensed CLIA Lab
March 29, 2012
WOBURN, Mass -- Courtagen Life Sciences, Inc., a privately held life sciences company that provides innovative proteomic and genomic products and services to the life sciences industry, today announced the introduction of their first genetic tests using next generation sequencing (NGS) technology, propriety bioinformatics platform and highly annotated, analytic capabilities to diagnose mitochondrial disease in [...]

